Korro Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Korro Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q2 2024.
  • Korro Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $967K, a 141% increase year-over-year.
  • Korro Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $3.46M.
  • Korro Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.38M, a 109% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.46M $967K +$566K +141% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2.9M $865K +$516K +148% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.38M -$1.29M +$13M +90.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$10.6M $2.93M -$2.67M -47.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$7.94M $401K -$4.16M -91.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$3.78M $349K -$4.92M -93.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.14M -$14.3M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $5.6M -$291K -4.94% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $4.56M -$1.53M -25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $5.27M +$655K +14.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $5.89M +$3.24M +123% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6.09M +$3.68M +153% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.61M +$2.45M +113% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q3 2020 $2.64M +$1.72M +186% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.41M +$929K +62.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $2.16M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $925K +$823K +807% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.48M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q3 2018 $102K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.